Yann Seimbille

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 23

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cancers

International journal of molecular sciences

ChemistryOpen

Erasmus MC

Université de Sherbrooke (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Erasmus MC Jul 01 2017

Netherlands

Assistant Professor & Head of RadioPharmaceutical Chemistry :: Radiology & Nuclear Medicine

TRIUMF Sep 01 2015 - Jun 30 2017

Canada

Research Scientist :: Life Sciences

University Hospital of Geneva Oct 01 2011 - Jun 30 2015

Switzerland

Assistant Professor & Head of the Cyclotron Unit :: Nuclear Medicine and Molecular Imaging

University Hospital of Geneva Apr 01 2006 - Sep 30 2011

Switzerland

SMER & Head of the Cyclotron Unit :: Nuclear Medicine & Molecular Imaging

David Geffen School of Medicine at UCLA Jan 01 2005 - Mar 31 2006

United States

Assistant Professor :: Molecular & Medical Pharmacology

David Geffen School of Medicine at UCLA Jul 01 2002 - Dec 31 2004

United States

Postdoctoral fellow :: Molecular & Medical Pharmacology

Education History

Université de Sherbrooke Sep 01 1998 - Jun 30 2002

Canada

PHD :: Nuclear Medicine & Radiobiology

Université Paris-Sud Sep 01 1996 - Jun 30 1997

France

MSC

Université de Bretagne Occidentale Sep 01 1992 - Jun 30 1996

France

BSC

Publications

Natasa Gaspar, Maryana Handula, Marcus C M Stroet, Kranthi M Panth, Joost Haeck, Thomas A Kirkland, Mary P Hall, Lance P Encell, Simone Dalm, Clemens W G M Löwik, Yann Seimbille, Laura Mezzanotte
A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells. International journal of molecular sciences 25 (15) (2024)
Natasa Gaspar, Maryana Handula, Marcus C M Stroet, Kranthi M Panth, Joost Haeck, Thomas A Kirkland, Mary P Hall, Lance P Encell, Simone Dalm, Clemens W G M Löwik, Yann Seimbille, Laura Mezzanotte
A Novel Luciferase-Based Reporter Gene Technology for Simultaneous Optical and Radionuclide Imaging of Cells. International journal of molecular sciences 25 (15) (2024)
Erika Murce, Savanne Beekman, Evelien Spaan, Maryana Handula, Debra Stuurman, Corrina de Ridder, Yann Seimbille
Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer. Molecules (Basel, Switzerland) 28 (10) (2023)
Erika Murce, Evelien Spaan, Savanne Beekman, Lilian van den Brink, Maryana Handula, Debra Stuurman, Corrina de Ridder, Simone U Dalm, Yann Seimbille
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Erika Murce, Stephen Ahenkorah, Savanne Beekman, Maryana Handula, Debra Stuurman, Corrina de Ridder, Frederik Cleeren, Yann Seimbille
Radiochemical and Biological Evaluation of 3p- C -NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Jason Beaufrez, Stéphane Guillouet, Yann Seimbille, Cécile Perrio
Synthesis, Fluorine-18 Radiolabeling, and In Vivo PET Imaging of a Hydrophilic Fluorosulfotetrazine. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Marjolein Verhoeven, Maryana Handula, Lilian van den Brink, Corrina M A de Ridder, Debra C Stuurman, Yann Seimbille, Simone U Dalm
Pre- and Intraoperative Visualization of GRPR-Expressing Solid Tumors: Preclinical Profiling of Novel Dual-Modality Probes for Nuclear and Fluorescence Imaging. Cancers 15 (7) (2023)
Erika Murce, Stephen Ahenkorah, Savanne Beekman, Maryana Handula, Debra Stuurman, Corrina de Ridder, Frederik Cleeren, Yann Seimbille
Radiochemical and Biological Evaluation of 3p- C -NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Dylan Chapeau, Sofia Koustoulidou, Maryana Handula, Savanne Beekman, Corrina de Ridder, Debra Stuurman, Erik de Blois, Yulia Buchatskaya, Karlijn van der Schilden, Marion de Jong, Mark W Konijnenberg, Yann Seimbille
[ 212 Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Maryana Handula, Marjolein Verhoeven, Kuo-Ting Chen, Joost Haeck, Marion de Jong, Simone U Dalm, Yann Seimbille
Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer. Pharmaceutics 14 (1) (2022)
Kuo-Ting Chen, Jim Nieuwenhuizen, Maryana Handula, Yann Seimbille
A novel clickable MSAP agent for dual fluorescence/nuclear labeling of biovectors. Organic & biomolecular chemistry 18 (31) (2022)
Marcus C M Stroet, Erik de Blois, Marion de Jong, Yann Seimbille, Laura Mezzanotte, Clemens W G M Löwik, Kranthi M Panth
Improved Multimodal Tumor Necrosis Imaging with IRDye800CW-DOTA Conjugated to an Albumin-Binding Domain. Cancers 14 (4) (2022)
Sofia Koustoulidou, Maryana Handula, Corrina de Ridder, Debra Stuurman, Savanne Beekman, Marion de Jong, Julie Nonnekens, Yann Seimbille
Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Kuo-Ting Chen, Yann Seimbille
New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents. International journal of molecular sciences 23 (11) (2022)
Marcus C M Stroet, Erik de Blois, Joost Haeck, Yann Seimbille, Laura Mezzanotte, Marion de Jong, Clemens W G M Löwik, Kranthi M Panth
In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors. Contrast media & molecular imaging 2021 (2021)
Maryana Handula, Kuo-Ting Chen, Yann Seimbille
IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications. Molecules (Basel, Switzerland) 26 (15) (2021)
Eline L Hooijman, Yozlem Chalashkan, Sui Wai Ling, Figen F Kahyargil, Marcel Segbers, Frank Bruchertseifer, Alfred Morgenstern, Yann Seimbille, Stijn L W Koolen, Tessa Brabander, Erik de Blois
Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC. Pharmaceutics 13 (5) (2021)
Ling Qiu, Ke Li, Wenyi Dong, Yann Seimbille, Qingzhu Liu, Feng Gao, Jianguo Lin
Tumor Microenvironment Responsive "Head-to-Foot" Self-Assembly Nanoplatform for Positron Emission Tomography Imaging in Living Subjects. ACS nano (2021)
Sofia Koustoulidou, Mark W H Hoorens, Simone U Dalm, Shweta Mahajan, Reno Debets, Yann Seimbille, Marion de Jong
Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy. Cancers 13 (5) (2021)
Ling Qiu, Xi Li, Gaochao Lv, Yann Seimbille, Ke Li, Ying Peng, Qingzhu Liu, Minhao Xie, Jianguo Lin
Radiofluorinated Smart Probes for Noninvasive PET Imaging of Legumain Activity in Living Subjects. Analytical chemistry 92 (17) (2020)
Kuo-Ting Chen, Christian Ieritano, Yann Seimbille
Early-Stage Incorporation Strategy for Regioselective Labeling of Peptides using the 2-Cyanobenzothiazole/1,2-Aminothiol Bioorthogonal Click Reaction. ChemistryOpen 7 (3) (2018)
Kuo-Ting Chen, Christian Ieritano, Yann Seimbille
Early-Stage Incorporation Strategy for Regioselective Labeling of Peptides using the 2-Cyanobenzothiazole/ 1,2-Aminothiol Bioorthogonal Click Reaction. ChemistryOpen 7 (3) (2018)
Didier J Colin, James A H Inkster, Stéphane Germain, Yann Seimbille
Preclinical validations of [18F]FPyPEGCBT-c(RGDfK): a 18F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis. EJNMMI radiopharmacy and chemistry 1 (1) (2016)

Yann Seimbille.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yann Seimbille